Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

SAFETY

  • Open Access
    Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
    Proton Rahman, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Iain B. McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P. Kollmeier, Elke Theander, Jenny Yu, Evan Leibowitz, A. Marilise Marrache and Laura C. Coates
    The Journal of Rheumatology June 1 2023, 50 (6) 769-780; DOI: https://doi.org/10.3899/jrheum.220928
  • You have access
    Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center
    Onorina Berardicurti, Viktoriya Pavlych, Ilenia Di Cola, Piero Ruscitti, Paola Di Benedetto, Luca Navarini, Annalisa Marino, Paola Cipriani and Roberto Giacomelli
    The Journal of Rheumatology February 1 2022, 49 (2) 171-175; DOI: https://doi.org/10.3899/jrheum.210441
  • Open Access
    Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
    Proton Rahman, Christopher T. Ritchlin, Philip S. Helliwell, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Shelly Kafka, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang and Iain B. McInnes
    The Journal of Rheumatology December 1 2021, 48 (12) 1815-1823; DOI: https://doi.org/10.3899/jrheum.201532
  • You have access
    Outcomes and Safety of Tumor Necrosis Factor Inhibitors in Reactive Arthritis: A Nationwide Experience from Iceland
    Bjarni Thorsteinsson, Arni J. Geirsson, Niels S. Krogh and Bjorn Gudbjornsson on behalf of ICEBIO
    The Journal of Rheumatology October 1 2020, 47 (10) 1575-1581; DOI: https://doi.org/10.3899/jrheum.191307
  • You have access
    Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials
    Louise Klokker, Dorthe B. Berthelsen, Thasia Woodworth, Kathleen M. Andersen, Daniel E. Furst, Dan Devoe, Paula R. Williamson, Maria E. Suarez-Almazor, Vibeke Strand, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lyn March, Victor S. Sloan, Peter Tugwell, Lee S. Simon and Robin Christensen
    The Journal of Rheumatology September 1 2019, 46 (9) 1173-1178; DOI: https://doi.org/10.3899/jrheum.190196
  • Open Access
    Safety Profile of Baricitinib in Patients with Active Rheumatoid Arthritis with over 2 Years Median Time in Treatment
    Josef S. Smolen, Mark C. Genovese, Tsutomu Takeuchi, David L. Hyslop, William L. Macias, Terence Rooney, Lei Chen, Christina L. Dickson, Jennifer Riddle Camp, Tracy E. Cardillo, Taeko Ishii and Kevin L. Winthrop
    The Journal of Rheumatology January 1 2019, 46 (1) 7-18; DOI: https://doi.org/10.3899/jrheum.171361
  • You have access
    Safety, and Humoral and Cell-mediated Immune Responses to Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis
    Jung Hee Koh, Jaeseon Lee, Seo Hwa Kim, Seung-Ki Kwok, Ji Hyeon Ju and Sung-Hwan Park
    The Journal of Rheumatology April 1 2018, 45 (4) 465-469; DOI: https://doi.org/10.3899/jrheum.170936
  • Open Access
    Safety and Efficacy of Baricitinib Through 128 Weeks in an Open-label, Longterm Extension Study in Patients with Rheumatoid Arthritis
    Edward C. Keystone, Mark C. Genovese, Douglas E. Schlichting, Inmaculada de la Torre, Scott D. Beattie, Terence P. Rooney and Peter C. Taylor
    The Journal of Rheumatology January 1 2018, 45 (1) 14-21; DOI: https://doi.org/10.3899/jrheum.161161
  • You have access
    Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group
    Louise Klokker, Peter Tugwell, Daniel E. Furst, Dan Devoe, Paula Williamson, Caroline B. Terwee, Maria E. Suarez-Almazor, Vibeke Strand, Thasia Woodworth, Amye L. Leong, Niti Goel, Maarten Boers, Peter M. Brooks, Lee S. Simon and Robin Christensen
    The Journal of Rheumatology December 1 2017, 44 (12) 1916-1919; DOI: https://doi.org/10.3899/jrheum.161105
  • You have access
    Safety of Biologic Agents in Elderly Patients with Rheumatoid Arthritis
    Atsuko Murota, Yuko Kaneko, Kunihiro Yamaoka and Tsutomu Takeuchi
    The Journal of Rheumatology November 1 2016, 43 (11) 1984-1988; DOI: https://doi.org/10.3899/jrheum.160012

Pages

  • Next
  • 1
  • 2
  • 3

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire